Sight Sciences, INC Form 4 insider transactions

Director Catherine Mazzacco acquired 17,366 restricted stock units in Sight Sciences, Inc. on June 6, 2024.

Director Brenda Larsen-Becker received 17,366 restricted stock units (RSUs) from Sight Sciences on June 6, 2024, under the company's Non-Employee Director Compensation Program.

Director Donald Zurbay received a grant of 17,366 restricted stock units (RSUs) from Sight Sciences, Inc. on June 6, 2024.

Director Staffan Encrantz received 17,366 restricted stock units (RSUs) from Sight Sciences on June 6, 2024, according to a Form 4 filing.

Director Erica Rogers received 17,366 restricted stock units (RSUs) from Sight Sciences on June 6, 2024, according to a Form 4 filing.

Alison Bauerlein, CFO of Sight Sciences, sold 13,066 shares of common stock on May 17, 2024, to cover tax liabilities related to vesting restricted stock units.

Jeremy B. Hayden, Chief Legal Officer of Sight Sciences, Inc., sold 4,893 shares of common stock on April 3, 2024, to cover tax liabilities related to vesting restricted stock units.

Sight Sciences CEO Paul Badawi sold 12,571 shares of common stock on April 3, 2024, to cover tax liabilities related to the vesting of restricted stock units.

David Badawi, Chief Technology Officer of Sight Sciences, sold 3,128 shares of common stock to cover tax liabilities related to vesting restricted stock units.

Sam Boong Park, Chief Operating Officer of Sight Sciences, Inc., sold 3,414 shares of common stock on April 3, 2024, to cover tax liabilities related to vesting restricted stock units.

Alison Bauerlein, CFO of Sight Sciences, sold 10,123 shares of common stock on April 3, 2024, to cover tax liabilities related to vesting restricted stock units.